The Fund is not expected to have any bias towards any specific issuer, industrial, geographic or other market sector and has preferred coverage in Europe within Biotechnology, Blockchain, HealthTech, Foodtech, MobilityTech, Sports, Information Security and Supply-chain Technology. Our company has a longstanding commitment to a diverse investment process– says Richard Piotrowski, non-exec director and strategic advisor to Anderton SICAV plc.
We target sectors that are experiencing above-average growth relative to the broader market. We utilize our proactive research program and dedicated Anderton Strategic Advisory Group (ASAG) of seasoned entrepreneurs to recognize important market trends early. We identify and invest in companies and management teams to capitalize on those trends. Our portfolio value creation and exit strategy is based on several core principles:
Anderton SICAV plc has developed a unique framework that focuses on six key areas for creating value and reducing risk:
Fund managers spend a significant amount of time, effort, and due diligence sourcing new deals, but often far too little time defining upside potential leading up to a sale. There is a significant opportunity to become more deeply involved in the selling process and take pre-emptive actions that will swing value realization in favor of our investors” – says Joanna Stec-Gamracy, Anderton SICAV plc investment committee member.
The Challenger Fund is one of the first funds that gives eligible investors access to VC/PE market investment opportunities.
The benefits of geographical diversification of assets and Revenue Based Investments.
Expand your investment universe to capture more opportunity with a global venture capital /private equity asset class.
Anderton SICAV plc - licensed and regulated. Working with renowned, trustworthy supervisors.
Our investment objective is to achieve mid-term capital growth 3x cash on cash with 3-4 years horizon.
We target sectors that are experiencing above-average growth relative to the broader market.